Markets
Stocks
Funds
Sectors
Tools
Treasury & Bonds
Overview
Market News
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
My Portfolio
Pieris Pharma (NQ: PIRS)
5.090 USD  -0.270 (-5.04%)
Official Closing Price  /  Updated: 4:31 PM EDT, Aug 17, 2018  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 447,100
Open 5.380
Bid (Size) 5.100 (2)
Ask (Size) 5.380 (15)
Prev. Close 5.360
Today's Range 5.030 - 5.380
52wk Range 4.430 - 9.750
Shares Outstanding 53,980,359
Dividend Yield N/A
Performance
YTD
-34.32%
-34.32%
1 Month
-12.69%
-12.69%
3 Month
-13.87%
-13.87%
6 Month
-40.54%
-40.54%
1 Year
+0.79%
+0.79%
Top News
More News
New Research Coverage Highlights Cincinnati Bell, BioCryst Pharmaceuticals, Shutterstock, Kopin, Lands' End, and Pieris Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 20
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cincinnati Bell Inc... Read More
from GlobeNewswire News Releases
Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and... Read More
from GlobeNewswire News Releases
More News
Read More
Pieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference
from GlobeNewswire News Releases
Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018
from GlobeNewswire News Releases
Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
from GlobeNewswire News Releases
Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference
from GlobeNewswire News Releases
Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018
from Marketwired
Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018
from Marketwired News Releases
Investor Expectations to Drive Momentum within Blackbaud, Pieris Pharmaceuticals, Sarepta Therapeutics, Cambrex, Stoneridge, and First Interstate BancSystem — Discovering Underlying Factors of Influen
from GlobeNewswire News Releases
Biotech Stocks' Research Reports Released on Pieris Pharma, Portola Pharma, Protalix BioTherapeutics, and Radius Health
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.